Pio Therapeutics
PIOtx is dedicated to developing novel, innovative, and targeted medicines to improve outcomes for cancer patients by harnessing and augmenting endogenous anti-tumor immunity. The company focuses on overcoming clinical challenges in cancer immunotherapy through novel therapies and collaborative efforts.
Industries
biotechnology
health-care
medical
therapeutics
Nr. of Employees
small (1-50)
Pio Therapeutics
Products
R&D pipeline of targeted cancer immunotherapies
Research and development programmes focused on novel targeted medicines intended to augment endogenous anti-tumor immunity; pipeline stage not specified on source pages.
R&D pipeline of targeted cancer immunotherapies
Research and development programmes focused on novel targeted medicines intended to augment endogenous anti-tumor immunity; pipeline stage not specified on source pages.
Services
Facilitates collaborative discussions and partnership opportunities with investors, scientific collaborators, and immunology experts to support therapeutic development.
Facilitates collaborative discussions and partnership opportunities with investors, scientific collaborators, and immunology experts to support therapeutic development.
Expertise Areas
- Cancer immunotherapy
- Therapeutic discovery
- Preclinical development
- Clinical development
Key Technologies
- Immuno-modulatory therapeutics
- Targeted oncology therapeutics
- Combination immunotherapy strategies
- Clinical development methodologies